- Risk Stratification Strategies Highlight Pediatric Oncology Conference🔍
- Overall survival prediction and risk stratification in patients with ...🔍
- NGS|based stratification refines the risk stratification in T|ALL and ...🔍
- A Validated Risk Stratification That Incorporates MAGIC Biomarkers ...🔍
- St. Jude research highlighted at annual meeting of the American ...🔍
- Risk stratification in children with cancer and febrile neutropenia🔍
- Enhanced Risk Stratification for Children and Young Adults with B ...🔍
- Strategies for risk stratification and cardiovascular toxicity prevention ...🔍
Risk Stratification Strategies Highlight Pediatric Oncology Conference
Risk Stratification Strategies Highlight Pediatric Oncology Conference
Risk Stratification Strategies Highlight Pediatric Oncology Conference ... Although conventional chemotherapy, surgery, and radiotherapy are the ...
Risk Stratification Strategies Highlight Pediatric Oncology Conference · Tony Berberabe ...
Overall survival prediction and risk stratification in patients with ...
Results: The discovery cohort yielded a C-index of 0.788 ± 0.049 in the test partitions, with a random survival forest (RSF) exhibiting the best ...
NGS-based stratification refines the risk stratification in T-ALL and ...
We externally validated this stratification in the pediatric cohort. NGS-based classifier was highly prognostic independently of minimal ...
A Validated Risk Stratification That Incorporates MAGIC Biomarkers ...
... pediatric GVHD, allowing for more tailored therapeutic strategies. Reference. Qayed M, Kapoor U, Gillespie S, et al. A Validated Risk ...
St. Jude research highlighted at annual meeting of the American ...
Neuroblastoma is a rare pediatric cancer that develops in neuroblasts, cells which develop into nerve cells. High-risk neuroblastoma has a ...
Risk stratification in children with cancer and febrile neutropenia
Identifying children with low-risk FN using a validated risk stratification strategy is recommended. This study prospectively validated nine ...
Enhanced Risk Stratification for Children and Young Adults with B ...
Current strategies to treat pediatric acute lymphoblastic leukemia rely on risk stratification algorithms using categorical data.
Strategies for risk stratification and cardiovascular toxicity prevention ...
This article focuses on the proposed strategies to stratify patients at risk of CV toxicity prior to cancer therapy, and highlights strategies to prevent ...
A risk stratification model for toxicities in phase 1 immuno-oncology ...
Among the 228 scorable studies, 120 (53%) scored 0, 65 (28%) scored 1-2, 43 (19%) scored 3+; 24 (11%) and 125 (55%) did not provide no. of pts ...
Fever and neutropenia in pediatric oncology and stem cell ...
While an ad hoc risk assessment adoption strategy allows tailoring of risk stratification among pediatric oncology/HCT centers, it somewhat ...
International Conference on Cellular Immunotherapy in Pediatric ...
Through presentations and discussions, we aim to: Capture the current state of cell therapy for pediatric cancer. Identify the most promising new cell therapies ...
The American Society of Pediatric Hematology/Oncology
American Society of Pediatric Hematology/Oncology (ASPHO) community of more than 1800 hematology/oncology professionals.
Abstracts of the 26th Annual Pediatric Hematology Oncology ...
Conference abstractOpen access. Reasons for high-risk stratification in paediatric B -cell acute lymphoblastic leukaemia. V. Hamsavardhini, T. Timothy, S ...
Risk-Stratified Radiotherapy in Pediatric Cancer - MDPI
We discuss the role of risk-stratification and personalized treatment for various pediatric cancer patients, with the goal being to improve tumor control.
Tailoring Therapy for Children With Neuroblastoma on the Basis of ...
A revised COG neuroblastoma risk classification schema that includes risk criteria harmonized with those currently used by SIOPEN and other ...
Wednesday, April 3 · Pre-Conference Session - Pediatric Vascular Anomalies: From Molecular Diagnostics to Clinical Change. Sponsored by Novartis · 10:30-11:30 am.
Program Pediatric Cancer 2024 | Meetings | AACR
Plenary Session 9: New Strategies for Early Phase Clinical Trials · 11 a.m. | Trial designs to find early signals of efficacy in rare pediatric cancers · 12 p.m. ...
AYA ALL: Overview and Risk Stratification - OncLive
Experts on acute lymphoblastic leukemia share their clinical experiences, describe high-risk features, and provide insights on risk ...
A Deep Learning Model for Pediatric Patient Risk Stratification
Currently, the state-of-the-art risk stratification models rely on groupers of diagnosis codes developed in the early 2000s, such as Diagnostic ...